$REGN Regeneron Pharma - 50d/200d ema Golden Cross on the daily chart last week after a solid earnings report in early August. Assuming bullish trend line holds, expecting continued gains over the next couple months.
Near term target - $391 (gap fill)
Medium term target - $420
TEVA: Teva Pharmaceutical Industries Ltd.
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
-Longterm downtrend broken
-Bull flag formation followed by breakout
-Breakout from overarching ascending wedge.
..... BULL SZN!
here's the monthly look, the next leg is coming folks.